Showing 249 results
  • View from “Hohlweg” passing under the Novartis Pavillon
    Image
    lock
    Locations / Image
    View from “Hohlweg” passing under the Novartis Pavillon

    View from “Hohlweg” passing under the Novartis Pavillon

  • View of the Novartis Pavillon towards Dreirosenbrücke and city center
    Image
    lock
    Locations / Image
    View of the Novartis Pavillon towards Dreirosenbrücke and city center

    View of the Novartis Pavillon towards Dreirosenbrücke and city center

  • View from Kleinbasel towards Novartis Campus Basel
    Image
    lock
    Locations / Image
    View from Kleinbasel towards Novartis Campus Basel

    View from Kleinbasel towards Novartis Campus Basel

  • Bird's eye view, Novartis Pavillon
    Image
    lock
    Locations / Image
    Bird's eye view, Novartis Pavillon

    Bird's eye view, Novartis Pavillon

  • Main entrance, Novartis Pavillon
    Image
    lock
    Locations / Image
    Main entrance, Novartis Pavillon

    Main entrance, Novartis Pavillon

  • John D. Young, Board member
    Image
    lock
    Leadership / Image
    John D. Young

    Member of the Board of Directors since March 7, 2023

  • Front cover of the 2022 Novartis in Society Integrated Report, Van Lacour, prostate cancer patient living in Natchez, Louisiana, who received a Novartis radioligand therapy
    PDF
    lock
    Publications / Report
    Novartis in Society Integrierter Geschäftsbericht 2022

    The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders. This is the German version of the report.

  • Production specialist manufacturing RNA therapies in Schweizerhalle, Switzerland
    Image
    lock
    Locations / Image
    Manufacturing RNA therapies in Schweizerhalle, Switzerland

    Manufacturing RNA therapies in Schweizerhalle, Switzerland

  • Production specialist on a computer working on RNA production in Schweizerhalle, Switzerland
    Image
    lock
    Locations / Image
    View of RNA production in Schweizerhalle, Switzerland

    View of RNA production in Schweizerhalle, Switzerland

  • Production specialist working on the production process of RNA therapies in Schweizerhalle, Switzerland
    Image
    lock
    Locations / Image
    Production process of RNA therapies in Schweizerhalle, Switzerland

    Production process of RNA therapies in Schweizerhalle, Switzerland

  • Screenshot of title and primary endpoint of plain language media summary on SUNNY trials results
    PDF
    lock
    Fact Sheet
    52-week results for Cosentyx® in hidradenitis suppurativa: A summary

    Discover the data published in The Lancet on the long-term effect of Cosentyx® (secukinumab) in adults with hidradenitis suppurativa from the SUNRISE and SUNSHINE trials.

  • Front cover of the 2022 Novartis in Society Integrated Report, Van Lacour, prostate cancer patient living in Natchez, Louisiana, who received a Novartis radioligand therapy
    PDF
    lock
    Publications / Report
    Novartis in Society Integrated Report 2022

    The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders.